Background: Homoisoflavonoids have been shown to have potent anti-proliferative activities in endothelial cells over other cell types and have demonstrated a strong antiangiogenic potential in vitro and in vivo in animal models of ocular neovascularization. Three species of Rhodocodon (Scilloideaea subfamily of the Asparagaceae family), endemic to Madagascar, R. cryptopodus, R. rotundus and R. cyathiformis, were investigated.Purpose: To isolate and test homoisoflavonoids for their antiangiogenic activity against human retinal microvascular endothelial cells (HRECs), as well as specificity against other ocular cell lines.
The roots of Erythrina lysistemon, growing
in
Egypt, yielded 24 flavonoid compounds, including 17 pterocarpans,
two isoflavanones, one flavanone, two isoflavans, one 2-arylbenzofuran,
and an isoflava-3-ene. Nine pterocarpans have not been reported previously
(7–9, 11–14, 19, and 20), and 11 are reported
here for the first time from this species. Structures were established
using HRESIMS, NMR, and circular dichroism techniques. Selected compounds
were tested for their ability to block the growth of human retinal
endothelial cells and antiangiogenic activity in vitro. The isoflavonoids 5 and 6, and the pterocarpans 1, 2, 4, 20, and 22 demonstrated
selective antiproliferative activities on endothelial cells compared
to a nonendothelial cell type, with concentration-dependent antiangiogenic
effects in vitro against HRECs, a cell type relevant to neovascular
eye diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.